Submit your email to push it up the queue
Itamar Medical, Inc., a leading innovator in the medical technology sector, is headquartered in the United States. Founded in 1997, the company has established itself as a key player in the field of sleep and respiratory health, particularly known for its advanced diagnostic solutions. Itamar Medical's flagship product, the WatchPAT, revolutionises sleep apnoea diagnosis by providing a unique, non-invasive method that enhances patient comfort and accuracy. With a strong presence in North America and Europe, Itamar Medical has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. The company is committed to improving patient outcomes through its cutting-edge technology, making it a trusted name in the healthcare industry. Its focus on innovation and quality sets Itamar Medical apart, ensuring it remains at the forefront of sleep medicine.
How does Itamar Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Itamar Medical, Inc.'s score of 72 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Itamar Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Asahi Kasei Corporation, which means that any emissions data or climate commitments may be inherited from this parent organisation. Asahi Kasei Corporation has its own climate initiatives and emissions performance, which may influence Itamar Medical's sustainability efforts. As of now, Itamar Medical has not set specific reduction targets or made notable climate pledges. The absence of documented reduction initiatives or commitments suggests that the company may still be in the early stages of developing its climate strategy. In the context of the industry, many companies are increasingly focusing on reducing their carbon footprints and aligning with global climate goals. Itamar Medical's future climate commitments and emissions data will be crucial for understanding its environmental impact and sustainability trajectory.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Scope 2 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Itamar Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.